SOLIGENIX, INC. — Director's Dealing 2013

Dec 9, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2013-12-05

Reporting Person: BREY ROBERT N (Chief Scientific Off., Sr. VP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-05	Stock Option (Right to Buy)	$2.01	A	10000	Acquired	2023-12-04	Common Stock (10000)	Direct

Footnotes

F1: The stock option vests immediately as to 2,500 shares and vests at a rate of 625 shares on each three (3) month anniversary of December 5, 2013.